An antibiotic used to treat infective diarrhoea could be an effective drug for a type of inflammatory bowel disease, a new study has found.

Patient activation, earned trust and health literacy at patient, provider and health system levels are critical to overcoming ...

Bill Holdings tried to break out ahead of earnings. The IBD 50 stock plunged 30% on earnings on Friday, triggering a sell ...

For older adults with inflammatory bowel disease (IBD), there was no significant difference in the risk of major ...

As Palantir continues to soar, industry peer Samsara is in big demand as the stock takes aim at fresh breakout.

IBD Aware, a wearable medical device in development for patients with inflammatory bowel disease, aims to improve disease ...

The Financial Select Sector SPDR Fund ETF trades in a buy zone as XLF holdings Berkshire Hathaway, Visa, Mastercard, JPMorgan ...

Construction materials supplier CRH cleared a buy point Thursday after announcing plans to unload its stake in SigmaRoc.

SAN FRANCISCO -- Janus kinase (JAK) inhibitors appeared to be a safe, effective option for treating inflammatory bowel ...

No significant difference in the risk for MACE was observed between patients with IBD receiving JAK vs TNF inhibitors.

Researchers from The Institute of Cancer Research in London have developed a new test that can predict colorectal cancer risk ...

A new method for detecting bowel cancer is more than 90% accurate at predicting which higher-risk people will develop the ...